These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 22404322)

  • 1. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen responsive genes as they affect hair growth.
    Sawaya ME; Keane RW; Blume-Peytavi U; Mullins DL; Nusbaum BP; Whiting D; Nicholson DW
    Eur J Dermatol; 2001; 11(4):304-8. PubMed ID: 11399535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
    Van Neste D
    Skin Pharmacol Physiol; 2006; 19(3):168-76. PubMed ID: 16679818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and alopecia.
    Kaufman KD
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):89-95. PubMed ID: 12573818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.